In re Galectin Therapeutics, Inc. Securities Litigation

ORDER

STEVE C. JONES, UNITED STATES DISTRICT JUDGE

This matter appears before the Court on Galectin Therapeutics, Inc. (“Galectin”), James C. Czirr, Rod D. Martin, Peter G. Traber, Jack W. Callicutt, and John F. Mauldin’s Motion to Dismiss (Doe No. [117]) and 10X Fund L.P.’s (“10X Fund”) Motion to Dismiss (Doc. No. [118]). Defendants move to dismiss with prejudice the Consolidated Class Action Complaint (“CCAC”) (Doc. No. [Ill]) for failure to state a claim upon which relief may be granted pursuant to Federal Rule of Civil Procedure 12(b)(6), Federal Rule of Civil Procedure 9(b), and the…